← Back to BIOA

BioAge Labs, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 05/08/2026Sep 2025Filed 06/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 05/08/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/11/2025Mar 2024Filed 06/11/2025
$2.5$2.8$2.1$2.4$1.5$0$0
−$26−$22−$20−$22−$13−$23−$14−$13
−$0.58−$0.52−$0.56−$0.60−$0.36−$6.70−$7.94−$7.76
45423636363.51.71.7

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.